| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
Laboratory of Cell Regulation and Carcinogenesis, National Cancer Institute, Bethesda, Maryland 20892-5055 [S. H. P., Y. Y., B. I. L., D. K. L., S-J. K.], and Intramural Research Support Program, Science Applications International Corporation-Frederick [M. C. B-R., T. F.], Laboratory of Leukocyte Biology, Frederick Cancer Research and Development Center [D. C. B., F. R.], Frederick, Maryland 21702
Abstract
Transforming growth factor (TGF)-ß1 plays an important role
during hematopoiesis. Previously, we had shown that the growth of a
v-Src-transformed myeloid cell line was markedly more inhibited by
TGF-ß treatment when compared with the wild-type myeloid cell line.
To investigate the increased growth sensitivity of the
v-Src-transformed myeloid cell line, 32D-src, to TGF-ß, we examined
expression of the TGF-ß type II
receptor (TGF-ß RII)
gene in myeloid cell lines. Northern blot analysis showed that
expression of
8- and 6-kb species of TGF-ß RII transcripts was
markedly increased in the 32D-src cell line. The expression of the
TGF-ß RII promoter linked to a reporter gene was increased 23-fold by
v-Src. DNA transfection and electrophoretic mobility shift assay
revealed that v-Src induces TGF-ß RII promoter activity through an
AP1/ATF2-like sequence (-219 to -172), ETS binding sites (+1 to +36),
and the inverted CCAAT box (-81 to -77). Novel DNA-protein complexes
with ETS binding sites are significantly increased in
v-src-transformed cell lines compared with the control
cell line. These results suggest that v-Src induces activity of the
TGF-ß RII promoter through multiple elements by inducing expression
of nuclear proteins interacting with these elements.
This article has been cited by other articles:
![]() |
J. L. Kopp, P. J. Wilder, M. Desler, J.-H. Kim, J. Hou, T. Nowling, and A. Rizzino Unique and Selective Effects of Five Ets Family Members, Elf3, Ets1, Ets2, PEA3, and PU.1, on the Promoter of the Type II Transforming Growth Factor-{beta} Receptor Gene J. Biol. Chem., May 7, 2004; 279(19): 19407 - 19420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Park, S. R. Lee, B. C. Kim, E. A. Cho, S. P. Patel, H.-B. Kang, E. A. Sausville, O. Nakanishi, J. B. Trepel, B. I. Lee, et al. Transcriptional Regulation of the Transforming Growth Factor beta Type II Receptor Gene by Histone Acetyltransferase and Deacetylase Is Mediated by NF-Y in Human Breast Cancer Cells J. Biol. Chem., February 8, 2002; 277(7): 5168 - 5174. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |